- Type / Class
- Equity / Common Stock
- Shares outstanding
- 235,704,040
- Total 13F shares
- 8,911,060
- Share change
- -317,017
- Total reported value
- $33,198,000
- Price per share
- $3.70
- Number of holders
- 19
- Value change
- -$1,175,766
- Number of buys
- 5
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 000899104?
CUSIP 000899104 identifies ADMA - ADMA BIOLOGICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 000899104:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$17,608,000 | — | 31 Mar 2017 | |
| Biomark Capital Management Co. LLC |
13F
|
Company |
0.61%
|
1,433,304
|
$6,995,000 | — | 31 Mar 2017 | |
| Consonance Capital Management LP |
13F
|
Company |
0.54%
|
1,273,933
|
$6,217,000 | — | 31 Mar 2017 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.44%
|
1,028,672
|
$5,020,000 | — | 31 Mar 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.31%
|
721,102
|
$3,519,000 | — | 31 Mar 2017 | |
| FMR LLC |
13F
|
Company |
0.17%
|
399,700
|
$1,951,000 | — | 31 Mar 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.15%
|
359,499
|
$1,754,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.06%
|
150,028
|
$732,000 | — | 31 Mar 2017 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.04%
|
100,000
|
$488,000 | — | 31 Mar 2017 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.02%
|
40,000
|
$195,000 | — | 31 Mar 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
32,696
|
$160,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
23,558
|
$114,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
19,069
|
$93,000 | — | 31 Mar 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
18,787
|
$91,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0%
|
10,555
|
$52,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
8,237
|
$40,000 | — | 31 Mar 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
766
|
$4,000 | — | 31 Mar 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
143
|
$1,000 | — | 31 Mar 2017 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q2 2017
As of 30 Jun 2017,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,911,060 shares.
The largest 10 holders included
Aisling Capital LLC, Biomark Capital Management Co. LLC, Consonance Capital Management LP, PERCEPTIVE ADVISORS LLC, Broadfin Capital, LLC, FMR LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Iguana Healthcare Management, LLC, and PRELUDE CAPITAL MANAGEMENT, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
17
Q2 2017 holders
19
Holder diff
2
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.